Ledger.Open graph →
SEC Form D · Amendment · filed December 26, 2024

EnPlusOne Biosciences Inc

Offering
$23.1M
Sold
$21.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Daniel H. Kasok · Watertown, MAExec · DirectorDavid P. Lang · Atlanta, GADirectorJ. Riggs · Santiago, F3DirectorGreg Rudin · Pittsburgh, PADirectorTodd R. Riecke · Covington, LAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗